GlassScriptPhysician profile
Kathryn E Bradley
NPI 1073834362
$2,023.97
in general payments reported to CMS, 2019-2025
17 companies · $583 in 2025
The $583 reported for 2025 was less than what a typical Neuromuscular Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $530).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $264 · 2020: $18.35 · 2021: $152 · 2022: $362 · 2023: $257 · 2024: $388 · 2025: $583.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,210 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,210.05 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $971.51 | 2019-2025 | Duopa, Ubrelvy |
| Medtronic, INC. | $263.13 | 2021-2025 | Percept PC Brainsense, Sensight |
| Teva Pharmaceuticals USA, INC. | $155.59 | 2019 | |
| Amneal Pharmaceuticals LLC | $93.75 | 2019-2022 | |
| Boston Scientific Corporation | $90.00 | 2023-2025 | General - Dbs |
| Mdd US Operations, LLC | $88.20 | 2024-2025 | Apokyn |
| Acadia Pharmaceuticals INC | $70.87 | 2019-2024 | Nuplazid |
| Acorda Therapeutics, INC | $63.56 | 2022 | |
| Neurocrine Biosciences, INC. | $57.36 | 2025 | |
| Eisai INC. | $30.00 | 2022 | |
| Biogen, INC. | $29.93 | 2022 | |
| Almatica Pharma LLC | $24.16 | 2021 | |
| Cala Health, INC. | $22.71 | 2022 | |
| Medtronic USA, INC. | $18.35 | 2020 | |
| Kyowa Kirin, INC. | $17.72 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $16.50 | 2021 | |
| Sunovion Pharmaceuticals INC. | $10.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Bradley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.